PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
about
Inhibition of Phospho-S6 Kinase, a Protein Involved in the Compensatory Adaptive Response, Increases the Efficacy of Paclitaxel in Reducing the Viability of Matrix-Attached Ovarian Cancer Cells.Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast CancerDDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.Protein Arrays III: Reverse-Phase Protein Arrays.Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple negative breast cancer.Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.
P2860
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
@en
type
label
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
@en
prefLabel
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
@en
P2093
P2860
P356
P1433
P1476
PKCiota promotes ovarian tumor progression through deregulation of cyclin E
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2015.301
P407
P577
2015-08-17T00:00:00Z